New Medication Approved for Drug-Resistant HIV

TUESDAY, March 6, 2018 — Trogarzo (ibalizumab-uiyk) has been approved by the U.S. Food and Drug Administration to treat AIDS-causing HIV that has not responded to other antiretroviral medications.
Trogarzo is given intravenously once every 14 days…
Source: Topamax